PLoS One:自然杀伤细胞识别疟原虫感染的红细胞

2012-04-14 tankuan 生物谷

被恶性疟原虫感染的红细胞(iRBC)在早期的免疫反应中,自然杀伤细胞(Natural killer cell,也译作NK细胞)是被激活的,这表明NK细胞与先天性抗寄生虫免疫反应有关。然而,NK细胞是否会直接识别iRBC,刺激iRBC是否需要辅助细胞呈递信号或是溶解性因子,这些问题目前还不明确。 近日,德国蒂宾根大学热带医学研究所 Meral Esen等人发现:被疟原虫感染的红细胞会通过宿主表达H

被恶性疟原虫感染的红细胞(iRBC)在早期的免疫反应中,自然杀伤细胞(Natural killer cell,也译作NK细胞)是被激活的,这表明NK细胞与先天性抗寄生虫免疫反应有关。然而,NK细胞是否会直接识别iRBC,刺激iRBC是否需要辅助细胞呈递信号或是溶解性因子,这些问题目前还不明确。

近日,德国蒂宾根大学热带医学研究所 Meral Esen等人发现:被疟原虫感染的红细胞会通过宿主表达Hsp70来引起NK细胞释放颗粒酶B,结果被感染的红细胞衰亡。相关论文发表在3月15日的美国《公共科学图书馆—综合》(PLoS One)上。

在近期的研究中,研究人员开展了关于“宿主细胞膜偶联的热休克蛋白70(Hsp70)会引起NK细胞对iRBC的毒性”的研究,这些NK细胞来自与疟疾病人捐赠的NK细胞以及培养的NK92细胞系。对于表达于iRBC细胞膜的Hsp70和HLA-E,以及可能性的活化的NK细胞受体(包括NKG2C和CD94),该研究运用了流式细胞术以及免疫印记对它们进行评估。

蛋白印迹、RT-PCR 以及ELISPOT分析表明:颗粒酶B(GzmB)的产生及释放都由没有受过刺激的NK细胞,以及Hsp70肽(TKD)预先刺激的NK细胞所启动。

研究结果表明,当iRBC细胞上没有HLA-E却有Hsp70时,会促进感染的宿主细胞成为了NK细胞调停的细胞毒性目标。iRBC与NK细胞的联系则引起了GzmB的释放,当GzmB被摄取后,iRBC通过一个不依赖穿孔素而是由GzmB调节的机制导致衰亡。

结果表明,NK细胞对iRBC的活性可以被TKD肽特异性增强,也可以因为Hsp70被抑制而降低到基础水平。因此,TKD可以作为一个革新性的免疫刺激物。(生物谷Bioon.com)

doi: 10.1371/journal.pone.0033774
PMC:
PMID:

Plasmodium falciparum-Infected Erythrocytes Induce Granzyme B by NK Cells through Expression of Host-Hsp70

Evelyn Bttger, Gabriele Multhoff, Jürgen F. J. Kun, Meral Esen

In the early immune response to Plasmodium falciparum-infected erythrocytes (iRBC), Natural Killer (NK) cells are activated, which suggests an important role in innate anti-parasitic immunity. However, it is not well understood whether NK cells directly recognize iRBC or whether stimulation of NK cells depends mainly on activating signals from accessory cells through cell-to-cell contact or soluble factors.In the present study, we investigated the influence of membrane-bound host Heat shock protein (Hsp) 70 in triggering cytotoxicity of NK cells from malaria-nave donors or the cell line NK92 against iRBC. Hsp70 and HLA-E membrane expression on iRBC and potential activatory NK cell receptors (NKG2C, CD94) were assessed by flow cytometry and immunoblot. Upon contact with iRBC, Granzyme B (GzmB) production and release was initiated by unstimulated and Hsp70-peptide (TKD) pre-stimulated NK cells, as determined by Western blot, RT-PCR and ELISPOT analysis. Eryptosis of iRBC was determined by Annexin V-staining.Our results suggest that presence of Hsp70 and absence of HLA-E on the membrane of iRBC prompt the infected host cells to become targets for NK cell-mediated cytotoxicity, as evidenced by impaired parasite development. Contact of iRBC with NK cells induced release of GzmB. We propose that following GzmB uptake, iRBC undergo eryptosis via a perforin-independent, GzmB-mediated mechanism.Since NK activity toward iRBC could be specifically enhanced by TKD peptide and abrogated to baseline levels by blocking Hsp70 exposure, we propose TKD as an innovative immunostimulatory agent to be tested as an adjunct to anti-parasitic treatments in vivo.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1789410, encodeId=ce241e894101f, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Nov 25 10:32:00 CST 2012, time=2012-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281900, encodeId=a65912819006c, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387817, encodeId=ae38138e81790, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487920, encodeId=cbb8148e920bc, content=<a href='/topic/show?id=72a98625851' target=_blank style='color:#2F92EE;'>#自然杀伤细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86258, encryptionId=72a98625851, topicName=自然杀伤细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43638387861, createdName=habb, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1789410, encodeId=ce241e894101f, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Nov 25 10:32:00 CST 2012, time=2012-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281900, encodeId=a65912819006c, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387817, encodeId=ae38138e81790, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487920, encodeId=cbb8148e920bc, content=<a href='/topic/show?id=72a98625851' target=_blank style='color:#2F92EE;'>#自然杀伤细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86258, encryptionId=72a98625851, topicName=自然杀伤细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43638387861, createdName=habb, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1789410, encodeId=ce241e894101f, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Nov 25 10:32:00 CST 2012, time=2012-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281900, encodeId=a65912819006c, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387817, encodeId=ae38138e81790, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487920, encodeId=cbb8148e920bc, content=<a href='/topic/show?id=72a98625851' target=_blank style='color:#2F92EE;'>#自然杀伤细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86258, encryptionId=72a98625851, topicName=自然杀伤细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43638387861, createdName=habb, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1789410, encodeId=ce241e894101f, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sun Nov 25 10:32:00 CST 2012, time=2012-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281900, encodeId=a65912819006c, content=<a href='/topic/show?id=3dece71531e' target=_blank style='color:#2F92EE;'>#红细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77153, encryptionId=3dece71531e, topicName=红细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c22f171, createdName=kord1982, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1387817, encodeId=ae38138e81790, content=<a href='/topic/show?id=25ffe04313d' target=_blank style='color:#2F92EE;'>#疟原虫#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70431, encryptionId=25ffe04313d, topicName=疟原虫)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1487920, encodeId=cbb8148e920bc, content=<a href='/topic/show?id=72a98625851' target=_blank style='color:#2F92EE;'>#自然杀伤细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86258, encryptionId=72a98625851, topicName=自然杀伤细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43638387861, createdName=habb, createdTime=Sun Apr 15 15:32:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]

相关资讯

抗CD52单抗在免疫系统中的作用新机制

来自哈佛医学院,布莱根妇女医院等处的研究人员发表了题为“Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients”的文章,发现一种用于治疗皮肤T细胞淋巴瘤的药物:抗CD52单抗(阿伦单抗,Alemtuzumab)在免疫系统中的作

近十年免疫学学科中国学者SCI十大发文期刊

2001-2011年SCI收录至少有一位中国学者(不包括台湾地区)发表的论文989,662篇(截至到2011年12月26日按出版年统计),其中免疫学(Immunology)学科论文9,723篇,9,723篇论文包括学术论文8,257篇、会议摘要718篇、综述283篇、会议论文279篇、通讯247篇、社论182篇、更正35篇、书评3篇、传记1篇等。 9,723篇文章共被引用69766次(其中200

Science:细胞死亡激发人免疫系统对病毒发起全面反攻

人IL-33结构图 瑞士日内瓦大学和德国柏林夏里特医科大学研究人员领导的一个科学研究小组完成了一项完全是史无前例的发现表明当遭遇病毒入侵时我们的免疫系统如何被激活而采取行动。探索这种机制在疫苗上的作用可能有望开发出新的阻止和治疗传染性疾病和癌症的方法。2012年2月9日,这一发现在线发表在《科学》期刊上。 杀伤性T细胞也称作细胞毒性T淋巴细胞,在我们的免疫系统中发挥着关键性作用。它们能够特

Clin. Exp. Immunol.:发现新方法导致嗜中性粒细胞产生胞外DNA杀菌网络

TLR4激活的血小板附着到嗜中性粒细胞上从而导致嗜中性粒细胞胞外杀菌网络(neutrophil extracellular traps, NETs)形成,图片来自Nature Medicine, 2007 Apr; 13(4):463-9,在此引用仅作研究之用,版权归Kubes P.所有。 英国伯明翰大学科学家发现一种方法来触发体内被称作嗜中性粒细胞的保护性白细胞产生一种强有力的抗细菌感染DNA

Science:细胞内随机性竞争决定B细胞命运

图片来自维基共享资源 来自澳大利亚沃尔特与伊丽莎-霍尔研究所(Walter and Eliza Hall Institute)的研究人员在研究能够制造抗体的免疫系统细胞即B细胞后,发现细胞对它们自己的命运也存在某种控制,从而在科学家们理解是什么决定细胞命运方面带来一场主要的震动。 B细胞能够有多种命运,其中较为更加常见的一些命运是死亡,分裂,成为能够分泌抗体的细胞或者改变它们制造的抗体。当

Pancreas:免疫治疗+化疗治胰腺癌有效

  日本学者将在3月份出版的《胰腺》(Pancreas)杂志发表的一项研究表明,对于标准治疗失败的晚期胰腺癌,采用基于树突细胞(DC)的免疫治疗联合化疗进行治疗可能会安全有效。   该研究针对46例标准治疗失败的不可手术胰腺癌患者,采用基于DC的免疫治疗[单纯DC疫苗或DC疫苗+淋巴因子激活的杀伤(LAK)细胞疗法]联合吉西他滨和/或S-1进行治疗。   结果,49例患者中,2例完全缓解,5例